Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Li-Fraumeni syndrome--a molecular and clinical review.

Literature DB >> 9218725

Li-Fraumeni syndrome--a molecular and clinical review.

J M Varley¹, D G Evans, J M Birch.

Abstract

Entities: Disease Mutation

Mesh：

Substances：

Year: 1997 PMID： 9218725 PMCID： PMC2223793 DOI： 10.1038/bjc.1997.328

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

132 in total

1. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.

Authors: C MacGeoch; G Turner; L G Bobrow; D M Barnes; D T Bishop; N K Spurr
Journal: J Med Genet Date: 1995-03 Impact factor: 6.318

Review 2. Predictive testing for germline mutations in the p53 gene: are all the questions answered?

Authors: R A Eeles
Journal: Eur J Cancer Date: 1993 Impact factor: 9.162

3. Complex replication error causes p53 mutation in a Li-Fraumeni family.

Authors: E A Strauss; M R Hosler; P Herzog; K Salhany; R Louie; C A Felix
Journal: Cancer Res Date: 1995-08-01 Impact factor: 12.701

4. Germ-line p53 mutation is uncommon in patients with triple primary cancers.

Authors: M Shiseki; R Nishikawa; H Yamamoto; A Ochiai; H Sugimura; N Shitara; Y Sameshima; H Mizoguchi; T Sugimura; J Yokota
Journal: Cancer Lett Date: 1993-09-15 Impact factor: 8.679

5. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

Authors: M Harvey; M J McArthur; C A Montgomery; J S Butel; A Bradley; L A Donehower
Journal: Nat Genet Date: 1993-11 Impact factor: 38.330

6. [Hereditary p53 mutation in a patient with multiple tumors: significance for genetic counseling].

Authors: R J Scott; F Krummenacher; J L Mary; W Weber; M Spycher; H Müller
Journal: Schweiz Med Wochenschr Date: 1993-06-26

7. Screening patients for heterozygous p53 mutations using a functional assay in yeast.

Authors: C Ishioka; T Frebourg; Y X Yan; M Vidal; S H Friend; S Schmidt; R Iggo
Journal: Nat Genet Date: 1993-10 Impact factor: 38.330

8. Cytogenetic response to G2-phase X irradiation in relation to DNA repair and radiosensitivity in a cancer-prone family with Li-Fraumeni syndrome.

Authors: R Parshad; F M Price; K F Pirollo; E H Chang; K K Sanford
Journal: Radiat Res Date: 1993-11 Impact factor: 2.841

9. Genomic stability and wild-type p53 function of lymphoblastoid cells with germ-line p53 mutation.

Authors: P Lalle; C Moyret-Lalle; Q Wang; J M Vialle; C Navarro; B Bressac-de Paillerets; J P Magaud; M Ozturk
Journal: Oncogene Date: 1995-06-15 Impact factor: 9.867

10. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.

Authors: H Nishino; A Knöll; V L Buettner; C S Frisk; Y Maruta; J Haavik; S S Sommer
Journal: Oncogene Date: 1995-07-20 Impact factor: 9.867

78 in total

1. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?

Authors: S A Roberts; A R Spreadborough; B Bulman; J B Barber; D G Evans; D Scott
Journal: Am J Hum Genet Date: 1999-09 Impact factor: 11.025

Review 2. Umbilical cord blood transplantation.

Authors: A M Will
Journal: Arch Dis Child Date: 1999-01 Impact factor: 3.791

Review 3. Genes and cancer.

Authors: J M Birch
Journal: Arch Dis Child Date: 1999-01 Impact factor: 3.791

4. Medulloblastoma in mice lacking p53 and PARP: all roads lead to Gli.

Authors: Charles G Eberhart
Journal: Am J Pathol Date: 2003-01 Impact factor: 4.307

Review 5. Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.

Authors: Jon D Larson; David A Largaespada
Journal: In Vivo Date: 2012 Jul-Aug Impact factor: 2.155